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ABSTRACT
Background: It is known that idiopathic chronic urticaria occasionally develops with Helicobacter pylori (H.
pylori) infection, but the association between urticaria and H. pylori remains unknown.
Methods: We focused on the relationship between the titer of anti H. pylori IgG antibodies and urticaria. Sixty-
five patients with idiopathic urticaria were divided into 3 groups by a difference of their titers. All patients in the
high titer (40 Uml) group underwent endoscopy of the upper gastrointestinal tract with antral biopsy for the
Rapid Urease Test (RUT) or a culture test. We investigated the relationship between the efficacy of eradication
therapy against H. pylori and urticaria.
Results: The positive rate for H. pylori was 100% (2020) by RUT or culture test in the high titer group. A CR
using antihistamines alone was 0% (020) in the high titer group, 27.2% (311) in the low titer group and 38.2%
(1334) in the negative group respectively. A CR or PR using antihistamines was 70% (1420) in the high titer
group, 81.8% (911) in the low titer group and 97.1% (3334) in the negative group. After successful eradica-
tion therapy, the CR was increased to 56% (916) in the high titer group.
Conclusions: Regardless of acute or chronic urticaria, a high titer of anti H. pylori IgG antibody can be an in-
dicator for undergoing upper endoscopy, and eradication therapy is strongly recommended. It will be necessary
to develop diagnostic criteria for urticaria associated with H. pylori.
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INTRODUCTION
Circumscribed, raised and erythematosus edema that
involves the superficial portion of the dermis is
known as urticaria. Urticaria rarely persists longer
than 24 hours, and can be divided into two types:
acute and chronic. Episodes of lesions of less than 4
weeks’ duration are considered acute, whereas those
persisting longer are termed chronic in Japan.1 On
the other hand, chronic urticaria is defined by the
presence of urticaria for a period of six weeks or
longer in Western contries.2 Idiopathic chronic urti-
caria occasionally develops with Helicobacter pylori
(H. pylori) infection. Recent observations have sug-
gested a possible etiopathogenic role for H. pylori in
some cases of chronic urticaria.3-8 It remains obscure
whether there is an association between urticaria and
H. pylori. Urticaria caused by H. pylori might be diag-
nosed by its gastric symptoms, a high titer of anti H.
pylori IgG antibody in the serum and the presence of
urticaria. However, it is necessary to confirm the
presence of H. pylori by the Rapid Urease Test (RUT)
or a culture test, etc. using biopsy specimens of the
gastric mucosa. Furthermore, if the urticaria re-
gresses after the H. pylori is eradicated, the associa-
tion between urticaria and H. pylori will be definite.
There have been no reports on the relationship be-
tween urticaria with a high titer of anti H. pylori IgG
antibodies in the serum and eradication therapy.
Herein, we describe the relationship between the
titer of anti H. pylori IgG antibody and urticaria. Fur-
thermore, we investigated the relationship between
the efficacy of eradication therapy against H. pylori
and urticatia.
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METHODS
Regardless of the urticaria being acute or chronic, all
the patients with urticaria attending the dermatology
clinic of Arida Municipal Hospital, Japan from April 1,
2008, to March 31, 2013 were screened. Sixty-five pa-
tients with idiopathic urticaria of no identifiable cause
were enrolled in this study after a physical examina-
tion and laboratory tests. Anti H. pylori IgG antibod-
ies in the serum were detected by enzyme-linked im-
munosorbent assay (ELISA). The patients with idi-
opathic urticaria were divided into 3 groups as fol-
lows: a high titer of anti H. pylori IgG antibody (40
Uml), a low titer of anti H. pylori IgG antibody (10
Uml, <40 Uml), and negative for anti H. pylori IgG
antibody (<10 Uml). The boundary line between
high and low titers was comprehensively assessed by
physical examination including gastric symptoms.
The high titer group included 13 patients with
chronic urticaria and 7 patients with acute urticaria,
and the mean age was 53.9 years old (male : female =
7 : 13). The low titer group included 4 patients with
chronic urticaria and 7 patients with acute urticaria,
and the mean age was 61.4 years old (male : female =
3 : 8). The negative group included 11 patients with
chronic urticaria and 23 patients with acute urticaria,
and the mean age was 43.5 years old (male : female =
10 : 24). The Chairman of the Ethical Committee in
our hospital orally approved the protocol for the re-
search project.
All patients started to take antihistamines orally at
the first visit to our hospital.
Informed consent was obtained from all patients
with a high titer of anti H. pylori IgG antibody and
those patients with gastric symptoms whose titer was
more than 20 Uml in the low titer group. After in-
formed consent, the patients underwent endoscopy of
the upper gastrointestinal tract with antral biopsy for
the Rapid Urease Test (RUT) or a culture test to iden-
tify H. pylori. If H. pylori was identified in the high
titer or low titer group, eradication therapy was per-
formed with oral antihistamines. Patients infected
with H. pylori were given first-line therapy consisting
of lansoprazole 60 mgday, amoxicillin 1500 mgday
and clarithromycin 400 mgday, for 7 days. If the H.
pylori persisted after the first line therapy, then the
patients were offered a second line therapy com-
prised of lansoprazole 60 mgday, amoxicillin 1500
mgday and metronidazole 500 mgday, for another
7 days. The efficacy of the eradication therapy was as-
sessed by a monoclonal fecal antigen assay or the
urea breath test. Those patients whose titer of anti H.
pylori IgG antibody was less than 20 Uml in the low
titer group and patients in the negative group took an-
tihistamines only without eradication therapy.
All patients were followed up during the study du-
ration of 1-6 months. Each patient’s objective re-
sponse to the treatment was judged using 3 variables:
a complete remission (CR-no need for antihista-
mines), a partial remission (PR- need for antihista-
mines at least one day to six days a week), and no re-
mission (NR- need for antihistamines every day, or in-
effective antihistamines).
Patients suffering from physical urticaria, patients
less than 16 years of age, pregnant females, patients
who had taken proton pump inhibitors antibiotics
within the preceding 4 weeks, and the presence of
other concomitant serious medical and surgical dis-
ease were excluded from the study.
STATISTICAL ANALYSIS
χ2-test was used to compare an incidence of gastric
symptoms and an efficacy of antihistamines alone in
three groups. Wilcoxon signed-rank test was used to
analyze an efficacy of successful eradication therapy
in the high titer group. CR, PR and NR was scored 0,
1 and 2 respectively in Wilcoxon signed-rank test.
RESULTS
Sixty-five patients with idiopathic urticaria were en-
rolled in this study. The positive rate of anti H. pylori
IgG antibodies was 47.7% (3165) in all patients with
idiopathic urticaria (high titer group: 20 cases, low
titer group: 11 cases, negative group: 34 cases). Gas-
tric symptoms including epigastric distress or gastral-
gia, etc. accompanied by gastritis or gastric ulcer
were observed in 65% (1320) of the high titer group,
in 27.2% (311) of the low titer group and 14.7% (5
34) of the negative group (Table 1). There was a sta-
tistically significant difference in the incidence of gas-
tric symptoms among the three groups (p = 0.0006).
The positive rate of H. pylori was 100% (2020) by
RUT or culture tests in the high titer group. Three
out of 11 patients showed titers of more than 20 Uml
and gastric symptoms in low titer group, and they un-
derwent endoscopy of the upper gastrointestinal
tract. The positive rate of H. pylori was 66.7% (23) by
RUT in the low titer group. Negative group patients
did not undergo endoscopy of the upper gastrointesti-
nal tract. A CR following antihistamines alone was 0%
(020) in the high titer group, 27.2% (311) in the low
titer group and 38.2% (1334) in the negative group
respectively. A CR or PR by antihistamines alone was
70% (1420) in the high titer group, 81.8% (911) in
the low titer group, and 97.1% (3334) in the negative
group. The efficacy of antihistamines only in the
three groups showed a statistically significant differ-
ence (p = 0.0053) (Table 2). The successful rate of
eradication including the second line therapy was 75%
(1620) in the high titer group. Even though the sec-
ond line therapy was performed, the fecal test was
still positive in three out of 4 unsuccessful cases. One
out of the 4 unsuccessful cases discontinued eradica-
tion therapy, because a drug eruption was observed.
The cases of NR by antihistamines alone were im-
proved after successful eradication therapy in the
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Fig.　1　Increase in complete remission of urticaria after successful eradication in high titer group 
(≥40 U/ml) (n = 16). A signifi cant improvement was seen after successful eradication therapy. 
When CR, PR and NR were scored 0, 1 and 2 respectively, statistical analyses of response 
score using Wilcoxon signed-rank test in both groups showed statistical signifi cance (p < 0.001).
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Table　1　Incidence of gastric symptoms in the three groups
High titer group (n = 20) 
(≥40 U/ml)
Low titer group (n = 11) 
(≥10 U/ml, <40 U/ml)
Negative group (n = 34) 
(<10 U/ml) p-value*
65 (%) 27.3 (%) 14.7 (%) 0.0006
 *χ2-test.
Table　2　Efficacy of antihistamines in the three groups
NR PR CR p-value*
High titer group (≥40 U/ml) (n = 20)   30 (%)   70 (%)    0 (%) ⎫
｜
⎬
｜
⎭
Low titer group (≥10 U/ml, <40 U/ml) (n = 11) 18.2 (%) 54.6 (%) 27.3 (%) 0.0053
Negative group (<10 U/ml) (n = 34)  2.9 (%) 58.8 (%) 38.2 (%)
 *χ2-test.
high titer group.
Furthermore, after successful eradication therapy,
the CR was raised up to 56% (916) in the high titer
group, but it was 0% (020) by antihistamines alone,
and a significant improvement was confirmed (P =
0.0002) (Fig. 1). In acute urticaria (n = 5) of the high
titer group, five PR changed to five CR after success-
ful eradication. In chronic urticaria (n = 11) of the
high titer group, five NR and six PR changed to seven
PR and four CR after successful eradication. On the
other hand, one out of 2 patients who had H. pylori di-
agnosed by RUT in the low titer group did not show a
CR, but underwent successful eradication therapy.
Another patient with H. pylori in the low titer group
was diagnosed with early gastric cancer plus idi-
opathic urticaria and showed NR to antihistamines
only. After surgical resection and eradication therapy,
NR changed to a CR.
DISCUSSION
Our present study showed that the positive rate of
anti H. pylori IgG antibody in idiopathic urticaria was
similar to the prevalence of H. pylori in chronic urti-
caria previously reported.6 On the other hand, it was
also reported that a positive rate of anti H. pylori IgG
antibody in sex and age-matched healthy control was
similar to that of idiopathic chronic urticaria which is
52%.6 In this study, H. pylori infection was detected in
100% (2020) of patients with idiopathic urticaria
whose anti H. pylori IgG titer was more than 40 Uml.
It is still unknown whether H. pylori could be de-
tected in those patients whose anti H. pylori IgG anti-
body titer was less than 20 Uml in the low titer
group, because we did not perform the upper endo-
scopy in such cases. It is believed that H. pylori was
associated with the pathogenesis of chronic urti-
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caria.5 On the other hand, there was no correlation
between H. pylori infection assessed by the (13)C-
urea breath test (UBT) and idiopathic chronic urit-
caria.9 In this study, the detection of H. pylori was
performed by upper endoscopy in the high titer
group and in some patients from the low titer group.
The discrepancy observed the association between
H. pylori and urticaria may be due to the different
methods used for the detection of H. pylori infection.
Our study showed that idiopathic urticaria with H.
pylori was significantly improved after eradication in
the high titer group. Previous reports have also
shown the resolution of urticarial symptoms after the
eradication of H. pylori.4-7 On the other hand, there
was a report of no correlation between eradication
therapy and the regression of urticaria.10 It was also
reported that the severity of urticarial symptoms was
greater in the H. pylori-positive group than in the H.
pylori-negative group.11 They also described that the
severity of the symptoms would depend on the den-
sity of the bacterial infection and the intensity of the
inflammatory infiltrates in the gastric biopsy.11 It was
also suggested that inflammation in the gastrointesti-
nal tract caused by H. pylori infection may have an
important role in the etiology of chronic urticaria.3
Our present study showed a tendency that the gastric
symptoms were especially pronounced in those pa-
tients with idiopathic urticaria in the high titer group
of anti H. pylori IgG antibody as compared to the low
titer or negative groups. Furthermore, the high titer
group of anti H. pylori IgG antibody showed lower re-
mission rates of a CR or PR by antihistamines than
the low titer or negative groups. Infection with H. py-
lori could influence the efficacy of the antihistamines
in urticaria. In this study, a CR was seen after suc-
cessful eradication therapy in the high titer group of
anti H. pylori IgG antibody. This suggested that eradi-
cation therapy was useful, especially for the high titer
group with anti H. pylori IgG antibody in idiopathic
urticaria. This result was supported by a recent re-
port that some patients with anti-histamine-resistant
chronic urticaria was improved after H. pylori eradica-
tion.12
The pathogenic mechanism that may exist between
urticaria and H. pylori remains unknown. It is well
known that the immunological response elicited by
H. pylori is an important determinant of the amount of
gastric mucosal damage. VacA, which is the virulent
H. pylori cytotoxin, may precipitate the host early re-
sponse to clear the bacteria, and may also contribute
to the pathogenesis of H. pylori-induced gastritis.13 H.
pylori causing inflammation in the gastrointestinal
tract might facilitate the absorption of antigens or un-
mask existing antigens.
In this study, idiopathic acute urticaria was also as-
sociated with H. pylori, as well as idiopathic chronic
urticaria. Eradication therapy was also useful for idi-
opathic acute urticaria. From our study, regardless of
it being acute or chronic urticaria, the high titer of
anti H. pylori IgG antibody can be an indicator for un-
dergoing upper endoscopy, and eradication therapy
would be strongly recommended. It will be necessary
to develop diagnostic criteria for urticaria associated
with H. pylori.
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